- Page 3/8
The dispute with Walmart (WMT-N) is a small deal, but the importance of the issue is for the potential of this becoming a much bigger issue internationally. Visa has a very good position and is the #1 card globally. It does more transactions and business than American Express (AXP-N), MasterCard (MA-N) and Discovery combined. Recently struck a deal to buy Visa Europe, which he feels is going to be very additive. Europeans tend to use more cash and less plastic, so there is lots of opportunity to catch some business there.
The dispute with Walmart (WMT-N) is a small deal, but the importance of the issue is for the potential of this becoming a much bigger issue internationally. Visa has a very good position and is the #1 card globally. It does more transactions and business than American Express (AXP-N), MasterCard (MA-N) and Discovery combined. Recently struck a deal to buy Visa Europe, which he feels is going to be very additive. Europeans tend to use more cash and less plastic, so there is lots of opportunity to catch some business there.
Given the nature of its business, tending to be more of a pharmacy, it probably won’t be too heavily harmed by Brexit. They plan to add Rite Aid (RAD-N), which will be very additive and a lot of opportunity.
Given the nature of its business, tending to be more of a pharmacy, it probably won’t be too heavily harmed by Brexit. They plan to add Rite Aid (RAD-N), which will be very additive and a lot of opportunity.
Has had concerns that the hepatitis C drugs they own, is highly effective, but there are competitors that are taking share. Also, has had price deterioration. A very expensive drug with a $90,000 price tag for a 90-day cure. Groups and the government have exercised a lot of pressure, and have been able to discount that price, which has reduced margins dramatically. It looks cheap, but this is a bit of a trap. Thinks they have developed a fairly good cash hoard. If they made a smart acquisition, he thinks he would be very additive to the company. Would probably not be his 1st choice in the space.
Has had concerns that the hepatitis C drugs they own, is highly effective, but there are competitors that are taking share. Also, has had price deterioration. A very expensive drug with a $90,000 price tag for a 90-day cure. Groups and the government have exercised a lot of pressure, and have been able to discount that price, which has reduced margins dramatically. It looks cheap, but this is a bit of a trap. Thinks they have developed a fairly good cash hoard. If they made a smart acquisition, he thinks he would be very additive to the company. Would probably not be his 1st choice in the space.
He wouldn’t try to time a purchase from a trading standpoint. Take a position and wait for a longer-term secular move in the banks, and you should be well rewarded.
He wouldn’t try to time a purchase from a trading standpoint. Take a position and wait for a longer-term secular move in the banks, and you should be well rewarded.
A developer and distributor of well-known products such as Revlon, Sunbeam, Vidal Sassoon, Dr. Scholl’s, etc. The company has done extremely well, but hit a bit of a hiccup in terms of growth in the last year or 2, but it appears that the growth has resumed. Trading at a mid-teens multiple, but have a very nice free cash flow yield of about 7.5%. This is a good time to buy.
A developer and distributor of well-known products such as Revlon, Sunbeam, Vidal Sassoon, Dr. Scholl’s, etc. The company has done extremely well, but hit a bit of a hiccup in terms of growth in the last year or 2, but it appears that the growth has resumed. Trading at a mid-teens multiple, but have a very nice free cash flow yield of about 7.5%. This is a good time to buy.
One of the most successful companies on the exchange. It has done extremely well through the years, and continues to do so. An online travel company, and owns booking.com, open table, Kayak. Very, very successful and high growth. Gross bookings rise anywhere from 25% to 30% year-over-year on a quarterly basis. He is looking for about $67 a share in earnings this year, and probably at $80 for next year.
One of the most successful companies on the exchange. It has done extremely well through the years, and continues to do so. An online travel company, and owns booking.com, open table, Kayak. Very, very successful and high growth. Gross bookings rise anywhere from 25% to 30% year-over-year on a quarterly basis. He is looking for about $67 a share in earnings this year, and probably at $80 for next year.
A derivative of the auto play. It manufactures exhausts and ride control systems. Some of the auto companies have had issues, but we are still seeing record levels of units. The run rate is still about 18 million units in North America, and about 60 million globally. What he likes is that it has a catalyst. Emission standards have been tightened, and will continue to do so.
A derivative of the auto play. It manufactures exhausts and ride control systems. Some of the auto companies have had issues, but we are still seeing record levels of units. The run rate is still about 18 million units in North America, and about 60 million globally. What he likes is that it has a catalyst. Emission standards have been tightened, and will continue to do so.
